Cysteine Injectable Solution
- Category(s)
- prescription
- SPL Type(s)
- Human Prescription
- Master SPL
- Sandoz Inc (2010-06-01)
- Oldest Current Product
- 2008-12-01
- License(s)
- UNAPPROVED DRUG OTHER MARKETING CATEGORY
- RxNORM
- INJECTABLE SOLUTION\CYSTEINE
- SPL Active
- INTRAVENOUS\INJECTION, SOLUTION\CYSTEINE HYDROCHLORIDE
- SPL Moiety
- INTRAVENOUS\INJECTION, SOLUTION\CYSTEINE
product(s) by strength(s)
cysteine hydrochloride 50 mg/ml injectable solution
# | id | category | labeler | first marketed | active ingredient(s) | route | dose form | spl |
---|
1 | 667580005 | UNAPPROVED DRUG OTHER MARKETING CATEGORY | Sandoz Inc | 2008-12-01 | CYSTEINE HYDROCHLORIDE | INTRAVENOUS | INJECTION, SOLUTION | fdfa6a13-8fa3-4439-8475-fadfb6071dca |
# | id | title | category | type | labeler | last update | version | product(s) |
---|
1 | fdfa6a13-8fa3-4439-8475-fadfb6071dca (view SPL) | L-Cysteine Hydrochloride Injection, USP 0.5 g/10 mL (50 mg/mL) | prescription | Human Prescription | Sandoz Inc | 2010-06-01 | 5 | 667580005 |